DMD and muscular dystrophy: Application of the translational enhancement technique is expected in various practical fields, including the production of useful proteins, such as antibodies in cultured animal cells, and gene therapy for muscular dystrophy caused by mutations in large dystrophin genes, which cannot be treated by replacement therapy.